Invivo Therapeutics Hldgs Corporation

CUSIP 46186M605COMNVIVDEURQ4 2025

Invivo Therapeutics Hldgs Corporation — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Feb 14, 2024

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 14, 2024	Armistice Capital, LLC	13G/A	5.0%	163.1K	SEC
2	Feb 13, 2024	Lind Global Fund II LP	13G/A	3.9%	125.5K	SEC
3	Feb 14, 2023	Armistice Capital, LLC	13G	10.0%	245.0K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Motiv8 Investments LLC	1	$0